High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease: whole exome sequencing 90% at 100X in ffpe tumor for NCI (devivo)

Ended Awarded Last action

Contract number
75N92021F00002
Awardee
Awarding agency
Obligated
$1,876,250

Award facts

Contract value 100% obligated
$1,876,250.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Cancer Institute National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Baltimore, MD 21218, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $1,876,250

About this award

This is a firm fixed-price delivery order under contract HHSN268201700006I|75N92021F00002, awarded by the National Cancer Institute (NCI) to The Johns Hopkins University, a private research university in Baltimore, Maryland. The $1,876,250.00 contract supports high-throughput genotyping and whole exome sequencing of FFPE tumor samples to study the genetic contributions to human health and disease. This work aligns with NCI's mission to conduct and support cancer research. The contract does not have a set-aside designation. Through prior prime and subcontract awards, The Johns Hopkins University has provided various biomedical research, public health, and scientific analysis services to federal agencies like the NIH, CDC, and DoD.

Quick answers

Who was awarded contract 75N92021F00002?

75N92021F00002 was awarded to The Johns Hopkins University by National Heart Lung and Blood Institute (National Institutes of Health) on July 16, 2021.

How much is contract 75N92021F00002 worth?

The government has obligated $1,876,250 on 75N92021F00002.

Which agency awarded contract 75N92021F00002?

National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92021F00002, with funding from National Cancer Institute (National Institutes of Health).

Is contract 75N92021F00002 an order under another contract?

Yes. 75N92021F00002 is a delivery order under HHSN268201700006I, an indefinite delivery contract.

Was contract 75N92021F00002 competed?

The extent of competition for 75N92021F00002 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award